Scinovex
article Open AccessTop 10% cited

Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

The American Journal of Cardiology · 1999 · Vol. 83(6) · pp. 897–902
Jagmeet SinghJane C. EvansDaniel LevyMartin G. LarsonLisa A. FreedDeborah L. FullerBirgitta T. LehmanEmelia J. Benjamin

Abstract

Little information is available on the prevalence and determinants of valvular regurgitation in the general population. This study sought to assess the prevalence and clinical determinants of mitral (MR), tricuspid (TR), and aortic (AR) regurgitation in a population-based cohort. Color Doppler echocardiography was performed in 1,696 men and 1,893 women (aged 54 +/- 10 years) attending a routine examination at the Framingham Study. After excluding technically poor echocardiograms, MR, TR, and AR were qualitatively graded from trace to severe. Multiple logistic regression analysis was used to examine the association of clinical variables with MR and TR (more than or equal to mild severity) and AR (more than or equal to trace severity). MR and TR of more than or equal to mild severity was seen in 19.0% and 14.8% of men and 19.1% and 18.4% of women, respectively, and AR of more than or equal to trace severity in 13.0% of men and 8.5% of women. The clinical determinants of MR were age (odds ratio [OR] 1.3/9.9 years, 95% confidence interval [CI] 1.2 to 1.5), hypertension (OR 1.6; 95% CI 1.2 to 2.0), and body mass index (OR 0.8/4.3 kg/m2; 95% CI 0.7 to 0.9). The determinants of TR were age (OR 1.5/9.9 years; 95% CI 1.3 to 1.7), body mass index (OR 0.7/4.3 kg/m2; 95% CI 0.6 to 0.8), and female gender (OR 1.2; 95% CI 1.0 to 1.6). The determinants of AR were age (OR 2.3/9.9 years; 95% CI 2.0 to 2.7) and male gender (OR 1.6; 95% CI 1.2 to 2.1). A substantial proportion of healthy men and women had detectable valvular regurgitation by color Doppler echocardiography. These data provide population-based estimates for comparison with patients taking anorectic drugs.

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk FactorsPulmonary Hypertension Research and TreatmentsCardiologyInternal medicineMedicineRegurgitation (circulation)Mitral regurgitationFramingham Heart StudyFramingham Risk ScoreDisease

MeSH terms

AdultAge FactorsAgedAged, 80 and overAortic Valve InsufficiencyFemaleHumansHypertensionMaleMiddle AgedMitral Valve InsufficiencyRisk FactorsTricuspid Valve InsufficiencyPrevalenceMultivariate Analysis
Citations
1,330
FWCI
5.97
field-weighted impact
References
26
Percentile
97%
vs. same field & year
Citations per year
Cited by
Heart Disease and Stroke Statistics—2012 Update
Circulation · 2011 · 7,221 citations
Heart Disease and Stroke Statistics—2011 Update
Circulation · 2010 · 6,167 citations
Heart Disease and Stroke Statistics—2010 Update
Circulation · 2009 · 5,595 citations
Heart Disease and Stroke Statistics—2009 Update
Circulation · 2009 · 3,916 citations
Heart Disease and Stroke Statistics—2013 Update
Circulation · 2012 · 5,180 citations
Heart Disease and Stroke Statistics—2009 Update
Circulation · 2008 · 3,129 citations
Impact of tricuspid regurgitation on long-term survival
Journal of the American College of Cardiology · 2004 · 1,646 citations
References
Applied Regression Analysis and Other Multivariable Methods
Technometrics · 1989 · 8,348 citations
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
American Journal of Epidemiology · 1979 · 1,661 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.